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Introduction
Multiple cellular dysfunctions underlie the molecular pathology 
of polyglutamine (polyQ) diseases, including Huntington’s dis-
ease (HD) and various spinocerebellar ataxias, which compose 
a major group of hereditary neurodegenerative disorders. Vari-
ous cellular functions, including transcription (Okazawa et al., 
2002; Sugars and Rubinsztein, 2003; Butler and Bates, 2006; 
Ross and Thompson, 2006), splicing (Jackson et al., 1998; 
Shibata et al., 2000; Waragai et al., 2000), proteasome activity 
(Johnston et al., 1998; Venkatraman et al., 2004; Bennett et al., 
2007), autophagy (Ravikumar et al., 2004; Iwata et al., 2005; 
Pandey et al., 2007), axonal transport (Gauthier et al., 2004),   
synaptic transmission (Li et al., 2000, 2004; Murphy et al., 2000),   
endocytosis (Metzler et al., 2001; Singaraja et al., 2002), mito-
chondrial membrane stability (Panov et al., 2002; Ruan et al., 
2004), energy metabolism (Cui et al., 2006; St-Pierre et al., 2006; 
Weydt et al., 2006), and oxidative stress response (Wyttenbach 
et al., 2002; Giorgini et al., 2005; for review see Lin and Beal, 
2006), are affected in neurons expressing mutant polyQ pro-
teins. Understanding of these pathogenic pathways is definitely 
necessary for developing therapeutics (Di Prospero and Fisch-
beck, 2005; Soong and Paulson, 2007).
In addition to these, activation of genotoxic stress sig-
naling has recently emerged as a new fundamental pathology 
(Giuliano et al., 2003; Qi et al., 2007). This hypothesis was 
derived from the observation that two critical mediators of 
the genotoxic stress signal pathway, p53 and p73, are acti-
vated in cultured cells and mouse models expressing mutant 
huntingtin (Htt) protein (Steffan et al., 2000; Bae et al., 2005; 
D
NA repair defends against naturally occurring or 
disease-associated DNA damage during the long 
lifespan of neurons and is implicated in polygluta-
mine disease pathology. In this study, we report that mutant 
huntingtin (Htt) expression in neurons causes double-strand 
breaks (DSBs) of genomic DNA, and Htt further promotes 
DSBs by impairing DNA repair. We identify Ku70, a compo-
nent of the DNA damage repair complex, as a mediator of the 
DNA repair dysfunction in mutant Htt–expressing neurons.   
Mutant Htt interacts with Ku70, impairs DNA-dependent 
protein kinase function in nonhomologous end joining, and 
consequently increases DSB accumulation. Expression of ex-
ogenous Ku70 rescues abnormal behavior and pathological 
phenotypes in the R6/2 mouse model of Huntington’s dis-
ease (HD). These results collectively suggest that Ku70 is a 
critical regulator of DNA damage in HD pathology.
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Involvement  of  OGG1  indicates  existence  of  base  damages, 
whereas our results of H2AX phosphorylation (H2AX) sug-
gest existence of DSBs in the polyQ pathology (Qi et al., 2007). 
Therefore, these two studies suggest that different types of DNA 
damage are induced in polyQ diseases.
The former study suggested that repair activity for oxidative 
DNA damage was not changed in nonneuronal tissues from a mild 
HD mouse model, R6/1 (Kovtun et al., 2007), whereas our data 
suggested a reduction of DSB repair activity in vivo in neurons of   
Drosophila melanogaster and severe mouse models of HD (Qi 
et al., 2007). Another study implicating polyQ-induced DNA dam-
age showed phosphorylation of H2AX in PC12 cells expressing 
expanded polyQ proteins as well as in fibroblasts from HD and 
SCA2 patients (Giuliano et al., 2003). Altogether, the questions re-
main of whether genomic double-strand DNA is actually cleaved 
especially in neurons, whether DNA repair is affected in polyQ dis-
eases, and which molecules mediate the DNA repair dysfunction.
Hoshino et al., 2006). The genotoxic stress hypothesis seems 
consistent with previous notions that nuclear events initiate the 
polyQ disease pathology (Klement et al., 1998; Saudou et al., 
1998; Katsuno et al., 2003). Moreover, regarding cell death, ac-
tivation of p53–p73 pathway leads to apoptosis in cultured cells 
(Bae et al., 2005) and to nonapoptotic, atypical cell death in pri-
mary neurons (Hoshino et al., 2006).
There has been previous evidence for accumulation of 
DNA damage in HD. Kovtun et al. (2007) demonstrated that 
accumulated oxidative DNA damage triggers activation of a 
single base excision repair enzyme OGG1 that enhances the 
CAG repeat instability during aging in somatic cells of polyQ 
diseases. Our group showed that two polyQ disease proteins 
(HD and SCA1) interact and reduce high mobility group pro-
tein B proteins (Qi et al., 2007) essential for the repair of DNA 
double-strand breaks (DSBs) occurring naturally in transcrip-
tion (Travers, 2003; Bianchi and Agresti, 2005; Ju et al., 2006). 
Figure 1.  Accumulation of DNA DSBs in HD brains. (A, left) Immunohistochemical detection of H2AX (green) and NeuN (red) in the striatum of R6/2 
and nontransgenic littermate (wt) mice at 4 and 12 wk of age. The H2AX signals were also merged with DAPI (Fig. S1). Arrows indicate activation of 
H2AX. Insets show higher magnification views of neurons indicated with arrowheads. (right) Immunofluorescence signal intensity of H2AX was quanti-
fied in >100 striatum neurons in nontransgenic littermates or R6/2 mice at 4, 6, and 12 wk of age. Student’s t test indicated a significant difference of 
H2AX levels between wild-type and R6/2 mouse brains at each age. Bars, 25 µm. (B) Immunoblot detection of H2AX level in wild-type and R6/2 mouse 
striatum protein extract (5 µl) at 4, 6, and 12 wk of age shows that H2AX was activated in R6/2 mice. (C) Immunohistochemical detection of H2AX 
(green) and NeuN (red) in the striatum of HttQ99 knock-in (Q99KI) and nontransgenic littermate (wild type) mice at 20, 45, and 80 wk of age. (right) 
Immunofluorescence signal intensity of H2AX was quantified in >100 striatal neurons in normal littermate (wild type) and HttQ99 knock-in (Q99KI) mice. 
Bar, 25 µm. (D) Striatal neurons of human HD patients show a remarkable increase of H2AX. The signal intensities of H2AX were analyzed in >100 
neurons of three HD patients and of three nonneurological disease controls. Bar, 50 µm. (E) Detection of mutant Htt–induced DNA DSBs by the neutral 
single-cell gel electrophoresis (comet assay). (left) Representative comet images of uninfected (Uninf), 10 µg/ml CPT-treated, 20 µg/ml -amanitin–treated 
(AMA), AxCA empty virus–infected (AxCA), or AxCAhtt111Q-infected (Htt111Q) neurons at 4 d. Bar, 10 µm. (right) Semiquantitative analysis of the results 
expressed as tail moment. Student’s t test analysis demonstrated a significant difference in tail moments between neurons infected by AxCA and those by 
Htt111Q. *, P < 0.001. Error bars indicate SEM.427 Impairment of DNA double-strand break repair in HD • Enokido et al.
after infection (Tagawa et al., 2004). Using neutral pH pre-
vents denaturing of double-strand DNA to detect DSBs but not 
single-strand breaks (SSBs) reported previously (Illuzzi et al, 
2009). Camptothecin (CPT), a specific inhibitor of DNA topo-
isomerase I (TopI), increased tail moment in the comet assay, 
indicating DSBs as a positive control (Fig. 1 E). As expected, 
expression of mutant Htt (Htt111Q) in cortical neurons simi-
larly induced DSBs (Fig. 1 E). The difference from normal Htt 
(Htt20Q) was statistically significant (Fig. 1 E). Interestingly, 
-amanitin, a specific inhibitor of RNA polymerase II, also in-
duced a substantial increase of DSBs (Fig. 1 E), agreeing with 
the recent notion that transcription is coupled with DNA repair 
Addressing these questions, we found that mutant Htt inter-
acts with Ku70, functionally impairs Ku70-dependent DNA- 
dependent protein kinase (DNA–PK) activity for nonhomologous 
end joining (NHEJ) of DSBs in vitro and in vivo, and contributes 
to the accumulation of DNA damage in neurons. Supplementa-
tion of Ku70 rescues mutant Htt–induced neurodegeneration in 
the R6/2 HD mouse model. These results suggest that impairment 
of DNA damage repair caused by the interaction between Ku70 
and mutant Htt is a critical pathological component of HD.
Results
Mutant Htt induces DSBs of genomic DNA 
in neurons
In this study, we first addressed whether mutant Htt protein   
induces  DSBs  in  vivo  by  analyzing  R6/2  transgenic  HD   
mice,  expressing  a  polyQ-containing  N-terminal  Htt  protein 
(Mangiarini et al., 1996). As a specific marker for DSBs, the levels 
of phosphorylated H2AX (H2AX) protein were investigated 
in neurons using fluorescence microscopy (Fig. 1). In our previ-
ous study, we showed that mutant Htt111Q protein expression 
increased H2AX levels in primary neurons (Qi et al., 2007). 
In immunohistochemistry experiments, we consistently found 
high signals of H2AX foci in striatal neurons of R6/2 mice 
(Fig. 1 A) that are located in the nuclei (Fig. S1 A). Correspond-
ingly, H2AX was increased in Western blot analysis (Fig. 1 B).   
DSBs were similarly detected by 53BP1, a marker molecule 
of DNA damage focusing at DSB points (Schultz et al., 2000), 
whereas activation of Rad51, another DNA damage marker re-
flecting homologous recombination (Lieber et al., 2003), was 
not observed (Fig. S1 B). In positive controls of irradiated mouse 
brain tissues, 53BP1 but not Rad51 was activated (Fig. S1 C). 
The discrepancy between 53BP1 and Rad51 was consistent with 
the observation that homologous end joining is used in dividing 
neural stem/progenitor cells, but NHEJ is the major DNA repair 
system in postmitotic neurons (Orii et al., 2006). The foci of 
H2AX and 53BP1 were merged (Fig. S1 D). In R6/2 mice, 
H2AX was already increased at 4 wk of age, corresponding 
to the onset of symptoms in this mouse model (Fig. 1, A and B), 
which suggests that DSBs are an early event in HD patho-
genesis. Interestingly, H2AX increased moderately in normal 
and transgenic mice during aging (Fig. 1, A and B), whereas 
the H2AX levels were significantly higher in R6/2 mice than 
in wild-type mice (Fig. 1, A and B).
We performed similar analyses with mutant Htt99Q knock-
in mice (Q99KI) whose disease onset is 45 wk (Ishiguro et al., 
2001; Sawada et al., 2007) and with postmortem human HD   
patient brains. In striatal neurons of Q99KI mice, H2AX was 
also activated before disease onset and increased during aging   
(Fig.  1  C).  Furthermore,  striatal  neurons  in  the  human  HD 
brains also showed high signals of H2AX in contrast to the 
nonneurological disease controls (Fig. 1 D).
To confirm the occurrence of mutant Htt–induced DSBs 
further, we directly analyzed cleavage of genomic DNA using   
the comet assay (Fairbairn et al., 1995; Olive and Banáth, 
2006). The assay was performed with rat primary cortical neu-
rons expressing mutant Htt111Q by adenovirus vector at 3 d 
Figure 2.  DNA damage precedes cell death. Chronological relationship 
among  H2AX,  caspase-3  activation,  and  viability  of  AxCAhtt111Q- 
infected primary cortical neurons. Caspase-3 activation was detected with 
anti–activated caspase-3 antibody that detects only the cleaved form of 
caspase-3. Activation of H2AX started at day 2 and preceded that of 
caspase-3 and cell death after day 5. Viability of neurons was evaluated 
by trypan blue staining. (A) Representative Western blots. (B) Quantitative 
analysis of signal intensities of H2AX and active caspase-3 and their 
chronological relationship. (C) Viability of primary cortical neurons ex-
pressing mutant Htt was estimated by trypan blue. Together with A–C, 
H2AX  phosphorylation  clearly  precedes  caspase-3  activation  and  cell 
death. Error bars indicate SEM.JCB • VOLUME 189 • NUMBER 3 • 2010   428
Figure 3.  Protein–protein interaction between Ku70 and mutant Htt. (A) IP assay with mouse brain samples. The nuclear extract from brain samples (cere-
bral cortex and striatum) of R6/2 or nontransgenic littermate (wt) mice at 9 wk were precipitated with anti-Ku70, -1C2, or -HD1 antibody and blotted with 
the other antibody. In the case of HD1 antibody, wild-type full-length Htt and aggregation of mutant Htt at the gel top are shown in input (arrow). In output, 
only the mutant Htt was coprecipitated with Ku70. As negative controls, mouse and rabbit IgG were used for precipitation. (B) IP assay showing interaction 
between endogenous Ku70 and overexpressed mutant Htt88Q exon 1 in HeLa cells. Interaction between normal Htt and endogenous Ku70 was not clear 429 Impairment of DNA double-strand break repair in HD • Enokido et al.
in this condition. (C) Deletion analysis demonstrated that mutant Htt interacts with the N-terminal domain of Ku70. (top) Diagram shows the constructs for 
the deletion analysis. (bottom) Coprecipitation pattern of GFP-HttQ88 with various Flag-Ku70 deletion mutants. NLS, nuclear localization signal. (D) The 
amount of mutant Htt necessary for interaction with endogenous Ku70 was titrated with Tet-on stable cells in which mutant Htt expression can be regulated 
by the concentration of tetracyclin in the medium. (top) Lanes 1–5 indicate a semiquantitative RT-PCR experiment with Htt-specific primers using cDNAs 
obtained from the Tet-on EGFP-HttQ88 stable cells treated with tetracyclin at different concentrations (0–100,00 pg/ml) for 48 h. The Htt-specific primers 
are designed to amplify the CAG repeat region to distinguish the endogenous Htt and induced EGFP-HttQ88 genes. The single asterisk denotes induced 
GFP-HttQ88 transcripts, the double asterisk denotes endogenous Htt transcripts (lanes 1–5). As a control, corresponding PCR with GAPDH-specific primers 
was performed. As a semiquantitative PCR calibration, PCR was performed with the Htt primers using plasmid DNAs, pEGFP-HttQ17 (lanes 6–11), and 
pEGFP-HttQ88 (lanes 12–17) as PCR templates with indicated amounts to evaluate the RT-PCR. (middle) Equal amounts of cell lysate from the Tet-on stable 
cell lines treated with the indicated concentration of tetracyclin for 48 h were blotted with anti-GFP antibody. (bottom) The lysates were also subjected to IP 
with anti-GFP antibody, and the precipitants were blotted with anti-Ku70 and GFP antibodies. IB, immunoblot.
 
(Ju et al., 2006) and our previous finding that impairment of 
transcription induces genotoxicity (Qi et al., 2007).
DNA damage occurs before apoptotic 
signal activation
To  know  whether  DNA  damage  could  be  causative  for  cell 
death, we analyzed the chronological relationship between 
H2AX  phosphorylation,  caspase-3  activation,  and  cell  death 
in Htt111Q-expressing primary cortical neurons (Fig. 2). The 
emergence of H2AX was observed at day 2 and clearly pre-
ceded the cleavage of caspase-3 that started at day 5 (Fig. 2).   
Cell death detected by trypan blue initiated at day 6 after   
caspase-3 activation. These results suggest that DNA damage 
indicated by H2AX activation is not the result of cell death and 
that the DSBs detected by comet assay (Fig. 1 E) could be an 
upstream event for mutant Htt–induced neuronal death.
Ku70 interacts with mutant Htt
An interactome dataset of Htt by Goehler et al. (2004) included 
a molecule relevant to DSB repair, Ku70, which was not iden-
tified in our previous proteome or transcriptome approaches   
(Qi et al., 2007; Tagawa et al., 2007). Ku70 plays a critical role 
in DSB repair (Lombard et al., 2005; for review see Sancar et al., 
2004). It forms a protein complex with Ku80, recruits DNA–PK 
catalytic subunit (DNA–PKcs; p460) complex to the DNA ends, 
and activates XRCC4/DNA ligase IV (for review see Sancar et al., 
2004). Ku70 by itself does not have the enzymatic activity for 
NHEJ of DSBs, whereas it is indispensable for the formation 
and kinase activity of the ternary complex composed of Ku70, 
Ku80, and DNA–PKcs (Lombard et al., 2005). Therefore, mu-
tant Htt might impair NHEJ of DSBs by the DNA–PK complex 
through interaction with Ku70.
To test this hypothesis, we examined the interaction be-
tween Ku70 and full-length mutant Htt in HEK293 cells by 
immunoprecipitation (IP; Fig. S2 A). The interaction was de-
tected either by Ku70 or Htt precipitation (Fig. S2 A). Next, we 
confirmed the interaction between the mutant Htt exon 1 peptide 
and endogenous Ku70 by IP with R6/2 mouse brain (cerebral 
cortex and striatum) tissues (Fig. 3 A). Although coprecipita-
tion of Ku70 and mutant Htt was observed with anti-polyQ and 
-Htt antibodies (1C2 and HD1), an interaction with wild-type 
Htt was not detected. In IPs with HeLa cells, an interaction of 
Ku70 with wild-type Htt could also not be shown (Fig. 3 B). We 
reexamined the interaction with wild-type Htt exon 1 using the 
LUMIER assay (luminescence-based mammalian interactome 
mapping technology; Barrios-Rodiles et al., 2005). When Ku70 
and wild-type Htt were overexpressed in the assay, their inter-
action was observed with low stringency (Fig. S2 B). These data 
collectively suggest that the shorter Htt exon 1 peptides, includ-
ing the polyQ tract, do interact with Ku70 and that mutant Htt 
interacts with Ku70 more strongly than wild-type Htt. We also 
found that mutant Htt did not interact with Ku80 or DNA–PKcs 
in IP (unpublished data).
We also performed IP with deletion clones of Ku70 to 
determine the interaction domain for mutant Htt (Fig. 3 C). 
Ku70 is composed of three domains (Fig. 3 C, top): the N-terminal 
domain, the DNA-binding domain, and the dimerization do-
main (Byrum et al. 2004). The interaction was observed with 
the construct 120–608 but not with 224–608, indicating that the 
mutant Htt exon 1 peptide interacts with the 120–223 region of 
the N-terminal domain. Functions of the N-terminal domain are 
not known in detail, whereas its deletion profoundly impairs 
DNA–PK activity, DNA repair after ionizing radiation, and DNA 
end binding of Ku70 (Jin and Weaver, 1997).
Furthermore, we titrated the amount of mutant Htt neces-
sary for the interaction with Ku70 by using stable T-Rex–HeLa 
cells in which expression levels of mutant Htt can be con-
trolled by the concentration of tetracyclin in the culture medium.   
RT-PCR was used to compare endogenous wild-type Htt and Tet-
induced mutant Htt (Fig. 3 D, top). Induced wild-type and mu-
tant Htt proteins were also checked by Western blots (Fig. 3 D,   
middle). Simultaneously, coprecipitation of Ku70 with Htt was 
tested. We found that an expression level of mutant Htt almost 
equivalent to the expression level of endogenous Htt was suffi-
cient for interaction with Ku70 (Fig. 3 D, bottom). A nonspecific 
band 75 kD interacting with anti-GFP antibody was observed 
in TetGFP-Htt17 cells. The nonspecific bands decreased in a 
tetracyclin concentration–dependent manner as a result of an 
unknown reason.
Immunocytochemistry of primary cortical neurons ex-
pressing mutant Htt also supported the association between Htt 
and Ku70 because mutant Htt and Ku70 were colocalized in 
inclusion bodies of primary cortical neurons (Fig. 4 A). Mutant 
Htt and Ku70 were also colocalized in striatal neurons of R6/2 
mice (Fig. 4 B). Higher magnification and confocal microscopic 
analyses revealed colocalization of Ku70 and mutant Htt both in 
inclusion bodies and the nucleoplasm (Fig. 4 C). Quantitative 
analysis of the signal intensities in the nucleus revealed that 
Ku70 distribution was strongly associated with that of mutant 
Htt, whereas ordinary distribution of Ku70 was homogenous JCB • VOLUME 189 • NUMBER 3 • 2010   430
Figure 4.  Colocalization of Ku70 and mutant Htt in the nucleus. (A) Immunocytochemical detection of colocalization of Ku70 and mutant Htt in cultured 
neurons at 4 d after mutant Htt infection (arrows). Endogenous Ku70 (red) colocalized with mutant Htt inclusion (green) in cultured neurons infected by 
AXCA-Htt111Q. Bars, 5 µm. (B) Immunohistochemical analysis showing colocalization of endogenous Ku70 (red) and mutant Htt (green) in striatal neurons 
of R6/2 mice (arrowheads) and age-matched nontransgenic littermates (wild type [wt]) at 12 wk. Bar, 25 µm. (C) High power magnification of striatal 
neurons of R6/2 mice and nontransgenic littermates (wild type) at 12 wk. Top and middle show ordinary and confocal microscopic images, respectively. 
(bottom) Graphs show quantitative analyses of signal intensities acquired from confocal images along the arrow line, showing that Ku70 and mutant Htt 
are colocalized. Bars, 5 µm. (D) H2AX is not colocalized with Ku70. IR, wild-type mouse brain irradiated with 20 Gy. Bar, 5 µm.431 Impairment of DNA double-strand break repair in HD • Enokido et al.
and not remarkably altered (Fig. 4 C). However, the foci of 
H2AX-indicating DSBs were distributed outside of the inclu-
sion bodies containing Ku70 and mutant Htt (Fig. 4 D).
Interaction between mutant Htt and  
Ku70 impairs DNA repair function of  
the DNA–PK complex
Next, we examined the effect of mutant Htt on DNA–PK activity. 
We prepared GST and GST mutant Htt (Htt110Q) fusion pro-
teins (Fig. S3 A), added them into the nuclear extract of HeLa 
cells containing Ku70, Ku80, and DNA–PKcs, and assayed   
the DNA–PK activity (Fig. 5). We found that GST-Htt110Q 
(exon  1)  but  not  GST  or  GST-Htt20Q  protein  suppressed 
DNA–PK activity (Fig. 5, A and B; and Fig. S3 B). Inter-
estingly, the suppression occurred only in the soluble frac-
tion  but  not  in  the  insoluble  fraction  of  mutant  Htt  protein 
(Fig. 5 A). Soluble GST-Htt110Q also impaired Ku70–DNA 
binding  (Fig.  5  B)  and  affected  Ku70–Ku80  interaction   
(Fig. 5 C), whereas GST-Htt20Q disturbed neither DNA–PK 
activity, Ku70–DNA binding, nor Ku70–Ku80 complex forma-
tion. Moreover, DNA–PK activity and Ku70–DNA interaction 
were impaired in the nuclear extract from brain tissues of R6/2 
Figure 5.  Mutant Htt affects DNA–PK activity 
and DNA–PK complex formation in vitro and 
in vivo. (A) The effect of soluble/insoluble frac-
tions of wild-type Htt (GST-Htt20Q) or mutant 
Htt  (GST-Htt110Q)  on  the  DNA–PK  activity 
was examined with HeLa cell nuclear extract. 
Addition of the supernatant fraction (S) but not 
the pellet fraction (P) of mutant Htt suppressed 
DNA–PK activity in a dose-dependent manner 
(mean ± SD; n = 3). Normal Htt or GST pro-
teins did not affect DNA–PK activity. Student’s 
t test confirmed the difference between GST 
and  GST-Htt110Q.  The  gradient  indicates 
that 5, 15, 50, or 150 ng of each fraction 
was  added  to  25  µl  of  reaction.  (B)  Ku70 
binding to DNA was assayed as described 
in  Materials  and  methods.  Supernatant  of 
GST-Htt110Q suppressed binding of Ku70 to 
the cleaved DNA fragments attached to the 
bottom of dishes. (C) IP was performed with 
the samples used for DNA–PK activity assay. 
GST-Htt110Q  supernatant  impaired  DNA- 
dependent  Ku70–Ku80  complex  formation. 
(D) DNA–PK activity was assayed with nuclear 
extract  from  brain  samples  (cerebral  cortex 
and striatum) of R6/2 or nontransgenic litter-
mate (wild type) mice. Mean ± SD (n = 4) are 
shown. Relative activities were calculated as 
the ratio to the mean value of wild-type mice. 
Corresponding data of R6/2; Ku70 double-
transgenic  mice  are  also  shown.  (E)  Ku70 
binding to DNA was assayed with nuclear ex-
tract from brain samples of R6/2 or nontrans-
genic littermate (wild type) mice. Mean ± SD; 
n = 3. Data of R6/2; Ku70 double-transgenic 
mice are also shown. (F) DNA–PK, Cdk1, and 
MAPK/ERK activities were assayed with the 
Tet-on EGFP-HttQ17 and EGFP-HttQ88 stable 
cell lines in which induced levels of EGFP-Htt 
can be regulated by the concentration of tetra-
cycline. The amount of mutant Htt necessary 
for  impairing  DNA–PK  activity  was  titrated. 
Nuclear extracts from the Tet-on GFP-HttQ17 
and GFP-HttQ88 stable cell lines treated with 
the indicated concentration of tetracyclin for 
48 h were subjected to the DNA–PK assay. 
The induction levels of GFP-HttQ17 and GFP-
HttQ88 were similar to Fig. 3 D because the 
two  experiments  were  performed  simultane-
ously. (top) An amount of mutant Htt equiva-
lent  to  the  endogenous  Htt  expression  level 
was sufficient for inhibition of DNA–PK activity. 
(bottom) Meanwhile, mutant Htt did not inhibit 
Cdk1 and MAPK/ERK activities. These results 
indicated that inhibition of DNA–PK was spe-
cific. Error bars indicate SEM.JCB • VOLUME 189 • NUMBER 3 • 2010   432
increased at day 1, decreased from day 1 to day 6 after infec-
tion, and returned to the initial level (Fig. 6, A–C). The early 
up-regulation of Ku70 and Ku80 probably occurs as a second-
ary response to DNA damage (Browne et al., 1999) induced by 
oxidative damage and by impaired DNA–PK activity as a result 
of an interaction between Ku70 and mutant Htt (Fig. 4 A). The 
decrease of Ku70 was blocked by the protease inhibitor MG132 
(Fig. 6 D), indicating that one part of the Ku70 and mutant Htt 
complex was degraded by the proteasome system, whereas 
another part forms intracellular aggregates.
In R6/2 mice from 4 to 12 wk, the amount of Ku70 protein 
was stable. This suggests that, after a short-term transient fluc-
tuation at the embryonic stage, the Ku70 protein expression 
level becomes stable at the equilibrium between increased syn-
thesis and increased degradation of Ku70. It is of note that Ku70 
signal levels in the nucleoplasm of inclusion-positive neurons 
were not reduced in vitro and in vivo (Fig. 4, A and B).
Ku70 is a bifunctional protein with different roles in the 
cytoplasm and nucleus. In the cytoplasm, Ku70 is suggested to 
associate with Bax to prevent apoptosis. Acetylation of Ku70 
seems to inhibit the interaction with Bax and promote apoptosis 
(Cohen et al., 2004). However, acetylated Ku70 was not found 
in cortical neurons before or after expression of mutant Htt (un-
published data). Altogether, the functional defect of Ku70 seems 
to be directly induced by interaction with mutant Htt rather than 
indirectly by sequestration or acetylation of Ku70.
DNA damage by mutant Htt depends on 
the dose of nonbound Ku70
To test the specificity of mutant Htt–induced DSBs, we used 
a Tet-on double-expression system for DsRed and Htt103Q. 
We found that doxycycline-induced expression of mutant Htt 
directly  triggered  GFP-H2AX  foci  formation  in  HeLa  cells 
(Fig. 7 A). Meanwhile, H2AX foci formation was not induced 
by  doxycycline  only  in  cells  that  did  not  express  Htt103Q   
(Fig. 7 B, arrow) or in cells expressing only DsRed (Fig. 7,   
A and C). These results confirm that mutant Htt (but not trans-
fection or doxycycline treatment) induces DSBs. The results 
mice when compared with nontransgenic littermates (Fig. 5,   
D and E; and Fig. S3 C). Simultaneously, we observed that 
transgenic expression of Ku70 rescued the decrease of DNA–PK 
activity and Ku70–DNA interaction in R6/2 mice (Fig. 5,   
D and E), which will be discussed later. As mutant Htt interacts 
only with Ku70 among three components of the DNA–PK com-
plex in IP assay (unpublished data), these results collectively 
suggest that the soluble form of mutant Htt directly disturbs 
the DNA–PK complex function through interaction with Ku70, 
which is consistent with the recent concept that soluble mutant 
Htt is toxic (Arrasate et al., 2004).
Furthermore, by using the T-Rex–HeLa cell system de-
scribed in Fig. 3 D, we titrated the amount of mutant Htt neces-
sary for inhibition of DNA–PK activity (Fig. 5 F). Expression 
levels  of  mutant  and  wild-type  Htt-EGFP  can  be  controlled 
via the tetracyclin concentration (Fig. 3 D). We found that an 
amount of mutant Htt almost equivalent to the endogenous Htt 
expression level was sufficient for inhibition of DNA–PK activity 
(Fig. 5 F). These results (Fig. 3 D and Fig. 5 F) support that 
mutant Htt expressed in human patients could impair Ku70- 
mediated DNA damage repair. Meanwhile, mutant Htt expres-
sion did not suppress activities of other kinases such as Cdk1/
Cdc2 or MAPK/extracellular-regulated kinase (ERK; Fig. 5 F), 
supporting the view that the effect of mutant Htt on DNA–PK 
could be specific to some extent. In yeast cells, Cdk1 is known 
to be essential for DNA damage checkpoint activation (Ira et al., 
2004). MAPK/ERK is known to be activated in the striatum of 
R6/2 mice, although a downstream kinase MSK1 is inactivated 
(Roze et al., 2008).
Mutant Htt induces Ku70 expression
In addition to the direct inhibition of DNA–PK activity through 
binding to Ku70, mutant Htt might influence expression lev-
els of Ku70 or of other components in the DNA–PK complex. 
Therefore, we tested how Ku70, Ku80, and DNA–PKcs respond 
to mutant Htt expression. Western blot analysis with primary 
cortical neurons expressing mutant Htt showed that protein 
levels of Ku70 and Ku80 but not of DNA–PKcs transiently 
Figure 6.  Mutant Htt affects Ku70 and Ku80 
expression in primary cortical neurons. (A) By   
Western  blotting,  Ku70  and  Ku80  expres-
sion in primary cortical neurons was investi-
gated chronologically after infection of AxCA, 
AxCAhtt20Q,  (Htt20Q),  or  AxCAhtt111Q 
(Htt111Q).  (B)  Mutant  Htt  does  not  affect 
expression  of  DNA–PKcs.  Immunoblot  detec-
tion of the change of DNA–PKcs expression 
in cultured neurons at 2 and 4 d after virus 
infection. Cultured neurons infected by AxCA, 
AxCAhtt20Q,  (Htt20Q),  or  AxCAhtt111Q 
(Htt111Q) were collected, and the cell lysates 
(5 µg) were immunoblotted by anti-DNA–PKcs 
(H-163)  antibodies.  (C)  The  chronological 
change  of  Ku70  expression  in  cytosol  and 
nucleus in cultured neurons. 1 µg nuclear (N) 
or cytosol (C) protein extract was blotted by 
anti-Ku70 antibody (H-308). Detection of GAPDH and HDAC3 was used to determine the purity of the fractions. Ku70 expression changed only in 
the nucleus. The lower GAPDH band in the nuclear fraction might be the nuclear translocation form (Sawa et al., 1997; Dastoor and Dreyer, 2001).   
(D) Effect of proteasome inhibitor on Ku70 protein levels in neurons was examined by immunoblots. Neurons infected by AxCA, AxCAhtt20Q (Htt20Q), or 
AxCAhtt111Q (Htt111Q) cultured in the presence or absence of proteasome inhibitor MG-132 were used for the analysis. 0.3 µM MG-132 was added to 
the culture medium 2 d after virus infection (day 2). Neurons were collected after 2 d of treatment with or without MG-132 (day 4).433 Impairment of DNA double-strand break repair in HD • Enokido et al.
Figure 7.  Mutant Htt specifically induces H2AX activation in a Ku70 dose-dependent manner. (A) After triple transfection of pTet-on, pTRE-DsRed-Htt103Q, 
and GFP-H2AX plasmids into HeLa cells, Htt expression was induced by addition of doxycycline; H2AX activation was detected by anti-H2AX antibody. 
The Htt103Q/DsRed-expressing cells showed foci formation of GFP-H2AX (Siino et al., 2002) only after induction. The cells expressing only DsRed did not 
show foci formation even after addition of doxycycline. CMV, cytomegalovirus. Bar, 5 µm. (B) In the same field, doxycycline did not induce foci of H2AX 
in nontransfected cells (arrows). Bar, 10 µm. (C) Immunocytochemistry (left) and Western blot analysis (right) show induction of Htt103Q by doxycycline. 
Bars, 5 µm. (D) Suppression of Ku70-enhanced activation of H2AX. pDsRed-Ku70-shRNA and pEGFP-Htt88Q were cotransfected into HeLa cells, and   
immunoblots were performed with total cells. pDsRed-nonsilencing shRNA, pEGFP-Htt17Q, or pEGFP was used as control. Transfection rates of each plasmid 
were confirmed to be equivalent. Activation levels of H2AX (H2AX band signals) were corrected by the band intensities of EGFP or its fusion proteins in 
the same blot, and the value of DsRed-nonsilencing shRNA/EGFP was defined as 1.0. (E) Confocal microscopic analysis of immunocytochemistry of H2AX 
in DsRed/EGFP double-positive cells. DsRed-Ku70-shRNA–expressing cells showed higher signals of H2AX in comparison with control cells. Bars, 5 µm.JCB • VOLUME 189 • NUMBER 3 • 2010   434
therefore deny the possibility that toxicity of adenovirus infec-
tion causes DSBs.
We also tested whether additional reduction of Ku70 en-
hances DSBs when the expression level of mutant Htt is equiva-
lent. We expressed mutant Htt labeled by EGFP in HeLa cells and 
repressed Ku70 by a coexpression vector of Ku70–short hairpin 
RNA (shRNA) and DsRed protein. We investigated DSBs by 
immunoblots with anti-H2AX antibody. As expected, reduction 
of Ku70 enhanced phosphorylation of H2AX (Fig. 7 D). Immuno-
cytochemistry of EGFP/DsRed double-positive cells with con-
focal microscopy supported the result of immunoblots (Fig. 7 E).
We also tried to test the effect of Ku70 reduction on mutant 
Htt–induced neurodegeneration in vivo by generating Ku70
/; 
mutant Htt
+/ mice from Ku70
/ mice (Gu et al., 2000). How-
ever, Ku70
/ mice were infertile in a separate experiment (un-
published data). Instead, we generated double-heterotransgenic 
mice (Ku70
+/; mutant Htt
+/), some of which showed more   
severe symptoms than R6/2 mice, although the difference was 
not confirmed statistically (unpublished data). However, in these 
double-heterozygous mice, Ku70 and DNA–PK activity were 
not significantly reduced in comparison with the wild-type mice 
(unpublished data). Therefore, we could not determine whether 
a  further  reduction  of  Ku70  accelerates  mutant  Htt–induced 
neurodegeneration at the mouse level.
Supplementation of Ku70 rescues 
neurodegeneration in mice
We next asked whether functional recovery of Ku70 by increas-
ing the amount of Ku70 rescues neurodegeneration in vivo. 
We hypothesized that additional overexpression of Ku70 would 
change the equilibrium between mutant Htt and Ku70 and would 
increase the amount of free and functional Ku70 (nonbound 
to mutant Htt). We generated transgenic mice overexpressing 
Ku70-Flag protein under the control of the neuron-specific 
enolase (NSE) enhancer/promoter (Fig. 8 A). The expression of 
Ku70-Flag protein was detected in the striatum of transgenic mice 
by Western blot analysis (Fig. 8 B) and immunohistochemistry 
(Fig. 8 C). Expression from the Ku70 transgene was also de-
tected in neurons throughout the brain, including cerebral cortex 
and hippocampus (Fig. S4 A). Macroscopic and phenotypic 
Figure 8.  Ku70 overexpression ameliorates 
mutant Htt–induced symptoms in mice. (A) The   
DNA  fragment  for  generation  of  mouse 
Ku70 transgenic mice. Mouse Ku70 flanked 
to  Flag  and  humanized  recombinant  GFPII 
(Agilent Technologies) are driven by rat NSE 
enhancer/promoter,  which  is  also  active  in 
mice. (B) Immunoblot (IB) detection of Ku70-
Flag expression in mouse striatum by anti-Flag 
antibody. Wt, wild type (nontransgenic litter-
mate). (C) Ku70-Flag expression was detected 
by anti-Flag antibody in immunohistochemis-
try in the Ku70 transgenic mouse brain. The 
expression of Ku70-Flag protein was detected 
in the striatal neurons of Ku70 transgenic mice 
by  anti-Flag  antibody.  Nontransgenic  litter-
mate  mice  show  nonspecific  stains  of  small 
vessels but not those of neurons. Bar, 50 µm. 
(D) In vivo effect of Ku70 overexpression on 
the H2AX level in the striatum was examined 
by  Western  blots  at  4  and  12  wk.  H2AX 
was  suppressed  in  R6/2  ×  Ku70  double-
transgenic mice. Anti-Ku70 antibody detected 
both  endogenous  Ku70  and  overexpressed 
Ku70-Flag.  The  mutant  Htt  bands  at  12  wk 
were shifted upward in comparison with the 
bands  at  4  wk,  indicating  aggregation  of 
mutant Htt. In the double-transgenic mice, the 
band sizes of mutant Htt were always slightly 
different from those in R6/2, suggesting that 
Ku70 might unexpectedly influence the con-
formation or aggregation state of mutant Htt 
(1C2). (right) Quantitative analysis of the left 
blot is shown. H2AX band intensities were 
corrected by GAPDH. *, P < 0.01 by Student’s 
t test. (E) Effect of neuron-specific Ku70 over-
expression  on  lifespan  was  evaluated  by   
Kaplan–Meier analysis. Nontransgenic litter-
mate (), R6/2 transgenic mice (), and R6/2 
and  Ku70  double-transgenic  mice  ()  are 
shown. Lifespan elongation was significant at 
the end point in log-rank test (P = 0.0007). The 
evaluators of these experiments were blinded. 
The number of mice is shown as (n = x). Error 
bars indicate SEM.435 Impairment of DNA double-strand break repair in HD • Enokido et al.
analysis showed no abnormality in Ku70 transgenic mice, and 
the birth rate was normal (unpublished data).
We crossed the Ku70 transgenic mice with R6/2 mice and 
generated double-transgenic mice. Western blot analysis showed 
Ku70-Flag expression in addition to endogenous Ku70 in double-
transgenic mice (Fig. 8 D). As expected, overexpression of 
Ku70 decreased H2AX at 4 and 12 wk, and the reduction was 
statistically confirmed (Fig. 8 D). We analyzed lifespan, brain 
weight, body weight, and motor functions of the double-transgenic 
mice (Fig. 8 E and Fig. S4 B). The abnormal clasping reflex 
was significantly reduced in double-transgenic mice until 12 wk 
(P < 0.01; Fig. 7 E). Lifespan was also significantly improved 
(log-rank test; P = 0.0007; Fig. 8 E). Rotarod staying time of 
double-transgenic mice was slightly improved at 4 wk (before 
onset) in comparison with R6/2 mice (P < 0.05), whereas the 
difference disappeared over time (Fig. S4 A). Brain weight was 
slightly improved at 4.5 wk (Fig. S4 A).
We further investigated histological changes of the double-
transgenic mice (Fig. 9 and Fig. S4 C). Consistent with Western 
blot analysis (Fig. 8 D), immunohistochemistry showed lower 
H2AX  signals  in  the  double-transgenic  mice  than  in  R6/2 
mice at 4 and 12 wk (Fig. 9). We found a unique change of the 
H2AX intranuclear distribution in striatal neurons of the double-
transgenic mice. H2AX was concentrated to fewer dots (Fig. 9) 
that were not merged with inclusion bodies of mutant Htt 
(Fig. S4 C) but costained with a nucleolus marker, fibrillarin 
(Fig. S5). Similar patterns were also observed in wild-type 
littermates (Fig. 9). The signals of H2AX in the nucleoplasm 
were clearly reduced in the double-transgenic mice in compari-
son with R6/2 mice (Fig. 9 and Fig. S5).
Notably,  H2AX  was  more  active  in  inclusion  body– 
negative striatal neurons in R6/2 mice at 4 wk (Fig. 9 A, bottom; 
and Fig. S4 C), whereas the activation extended to inclusion 
body–positive striatal neurons at 12 wk (Fig. 9 B and Fig. S4 C).   
The negative relationship between H2AX and inclusion bod-
ies at 4 wk was consistent with the suppression of DNA–PK 
activity by soluble mutant Htt (Fig. 4 A) and with the view 
that inclusion bodies may be protective against HD pathology   
(Arrasate et al., 2004).
Furthermore,  we  tested  DNA–PK  activity  and  DNA–
Ku70 interaction in brain tissues of nontransgenic, R6/2, and 
Ku70-R6/2  double-transgenic  mice.  DNA–PK  activity  and 
Ku70–DNA binding impaired in R6/2 mice were recovered in 
double-transgenic mice (Fig. 5, D and E), supporting the idea 
that the impairment of Ku70-mediated DNA repair contributes 
to the toxic effect of mutant Htt in vivo.
Discussion
In  this  study,  beyond  previously  published  observations  on 
DNA damage signals (Giuliano et al., 2003; Qi et al., 2007), 
Figure 9.  Ku70 overexpression ameliorates mutant Htt–induced activa-
tion of H2AX in mouse striatal neurons in vivo. Immunohistochemistry of 
striatal neurons of R6/2 mice or of R6/2 × Ku70 double-transgenic mice 
at 4 wk. Anti-NeuN and -H2AX antibodies were used. Bars, 10 µm. 
(bottom) Quantitative analysis of >100 neurons from four nontransgenic   
littermates,  four  R6/2,  and  four  double-transgenic  mice  is  shown.  The 
mean values of four mice were compared among groups. The signals of 
H2AX in the nucleoplasm were reduced in comparison with R6/2. The 
H2AX signals were focused to the nucleoli in double-transgenic mice.   
*, P < 0.01 by Student’s t test (n = 4). Error bars indicate SEM.
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we found that expression of mutant Htt eventually leads to 
DSBs of genomic DNA in affected neurons (Fig. 1) and sug-
gest that impairment of Ku70 contributes to the increase of 
DSBs in the HD pathology (Figs. 2–9). In DNA damage repair, 
Ku70 and Ku80 first detect DSBs and assemble at the foci. 
The Ku70–Ku80 heterodimer recruits DNA–PKcs and initiates 
the DNA damage repair reactions of XRCC4/DNAligase IV 
(Lombard et al., 2005). Mutant Htt interacts (Fig. 3, A and B) 
and colocalizes with Ku70 in striatal neurons in vivo (Fig. 4). 
In vitro assays revealed that Htt-GST but not GST protein in-
hibits DNA–PK activity (Fig. 5 A). Ku70 binding to DNA and 
Ku70–Ku80 interaction is also impaired by mutant Htt (Fig. 5,   
B  and  C).  Especially  soluble,  rather  than  insoluble,  mutant 
Htt impairs DNA–PK activity through the binding to Ku70 
(Fig. 5 A). Brain tissues of R6/2 transgenic mice have a lower 
DNA–PK activity (Fig. 5 D). Supplementation of the Ku70 sig-
nificantly rescues DNA–PK (Fig. 5 D) and degenerative pheno-
types in the R6/2 mouse model of HD even though the increase 
of Ku70 is relatively small (Fig. 8 and Fig. 9). These results 
collectively suggest that Ku70 is a new critical player in the 
DNA damage–linked pathologies of HD (Fig. 10).
In this study, we provided direct evidence of mutant Htt– 
induced DSBs in primary neurons (Fig. 1 E), whereas we 
also used H2AX phosphorylation as the DSB marker in sev-
eral experiments. Because DNA–PK was reported to phos-
phorylate H2AX (Stiff et al., 2004), one might ask whether 
the reduced DNA–PK activity (Fig. 5) could be contradictory   
to H2AX phosphorylation. However, other kinases, such as ataxia 
telangiectasia mutated (ATM), a mediator of DNA damage– 
induced cell death signaling (Lombard et al., 2005; for review 
see Sancar et al., 2004), are also known to phosphorylate H2AX 
(Fernandez-Capetillo et al., 2004; Lu et al., 2006), and acti-
vation of ATM has been observed in the HD pathology (Qi 
et al., 2007). Therefore, our hypothesis fits very well with this 
experimental evidence.
Previous studies indicated that mutant Htt induces oxida-
tive stress (for review see Lin and Beal, 2006), leading to DSBs 
(for review see Sancar et al., 2004). Consistently, we observed 
the increase of 8-oxo-dG in our primary neurons expressing 
mutant Htt (unpublished data). In addition, we recently found 
that a mitochondrial protein, Omi/HtrA2, which keeps mito-
chondrial homeostasis, is reduced in HD pathology (Inagaki 
et al., 2008). These results agree with the hypothesis that oxida-
tive stress from mitochondria is critical for an increase of DNA 
damage in HD pathology. However, oxidative stress may not be 
the sole factor to promote DSBs. Our experiments show that 
impairment  of  DNA  repair  through  the  interaction  between 
Ku70 and mutant Htt accelerates accumulation of DSBs and 
causes neuronal dysfunction from an early stage of the HD 
pathology. The results support DNA repair to be a critical factor 
promoting DSBs. This is consistent with our previous result, 
showing that a reduction of HMGBs essential for architectural 
DNA alteration (Thomas and Travers, 2001) leads to genotoxic 
stress (Qi et al., 2007). It is also in line with previous findings 
that nuclear events largely initiate polyQ pathologies (Klement 
et al., 1998; Saudou et al., 1998; Katsuno et al., 2003).
The R6/2 mouse is the most difficult to be remedied 
among various mouse models of neurodegeneration (for review 
see Gil and Rego, 2009). One study listed showed a lifespan 
elongation of 40%, the others mostly showed a minor (5–15%) 
or no effect. Because lifespan elongation by Ku70 reaches 30% 
in our study (Fig. 8 E) even though the increase of Ku70 pro-
tein in the double-transgenic mice is relatively small (Fig. 8 D), 
Ku70-mediated DNA repair dysfunction can be considered as 
a critical component among various HD pathologies in vivo. If 
Ku70 could be up-regulated more efficiently in a milder mouse 
model of HD, a higher therapeutic effect might be expected. 
To support this idea, we found that coexpression of Ku70 sub-
stantially elongated survival of Drosophila expressing mutant 
human Htt (unpublished data).
Several  aging  disorders  and  some  autosomal  recessive 
neurodegenerative diseases are caused by mutations of DNA 
repair  genes. Aging  disorders  such  as  Cockayne  syndrome 
type A (Henning et al., 1995), type B (Troelstra et al., 1992), and 
Werner syndrome (Oshima et al., 1996; Yu et al., 1996) are 
caused by mutations in DNA repair genes. The autosomal 
recessive cerebellar ataxias, including AOA1/EAOH (Date et al., 
2001), AOA2 (Suraweera et al., 2007), and SCAN1 (Takashima 
et al., 2002; El-Khamisy et al., 2005), are also caused by muta-
tions of DNA repair genes. HD seems to share DNA repair dys-
function  as  a  critical  pathology  with  these  disorders.  The 
difference of the HD pathology from aging disorders (de Boer 
et al., 2002) is that the DNA repair dysfunction is not directly or 
Figure 10.  A model of DNA damage repair dysfunction in the HD pathol-
ogy mediated by Ku70. Interaction between mutant Htt and Ku70 inhibits 
complex formation among Ku70, Ku80, and DNA–PKcs and represses 
the DSB repair activity of the DNA–PK complex. Ku70 bound to mutant 
Htt undergoes protein degradation by the proteasome system. Coaggre-
gation to inclusion bodies also occurs, but functional impairment of the 
DNA–PK complex occurs more promptly by interaction before quantitative 
alteration of Ku70.437 Impairment of DNA double-strand break repair in HD • Enokido et al.
anesthesia with ether. Their brains were dissected, minced into fine pieces, 
and rinsed with PBS. After incubation with 0.0125% trypsin at 37°C for 
10 min, the pieces were washed twice with DME (Nissui) containing 10% 
fetal bovine serum, 25 mM D-glucose, 4 mM L-glutamine, and 25 µg/ml 
gentamycin and gently triturated with blue tips and filtered through a 
nylon mesh (Falcon 2350; BD) to remove any debris. Cells were seeded 
onto dishes (Corning) coated with poly-l-lysine (Sigma-Aldrich) at 1.8 × 
10
5 cells/cm
2 and cultured at 37°C and 5% CO2. To remove proliferating 
glial cells, arabinosylcytosine (Sigma-Aldrich) was added to the culture 
medium (4 µM) on the next day. 4 d after plating, neurons were infected 
by adenovirus vectors. Antioxidants, N-acetylcysteine (Sigma-Aldrich), 
l--glutamyl-l-cysteinyl ethyl glycinate (Sigma-Aldrich), and coenzymeQ10 
(Sigma-Aldrich) were added 3 h after infection. The proteasome inhibitor 
MG-132 (Sigma-Aldrich) was dissolved in DMSO and added to the media 
to the appropriate final concentration of 0.3 µM. DMSO was added to the 
media without MG-132 as control.
Immunoblotting
For Western blot sampling, brain tissues of mutant Htt transgenic R6/2 
mice (B6CBA-Tg [HD exon 1] 62Gpb/1J; The Jackson Laboratory) stria-
tum or of nontransgenic littermate (wild type) were washed three times by 
ice-cold PBS and dissolved in lysis buffer containing 62.5 mM Tris/HCl,   
pH 6.8, 2% (wt/vol) SDS, 2.5% (vol/vol) 2-mercaptoethanol, and 5% 
(vol/vol) glycerol. The samples from culture cells were prepared similarly. 
Protein concentration was quantified by using the BCA method (Micro BCA 
Protein Assay Reagent kit; Thermo Fisher Scientific).
The dilution conditions of primary and secondary antibodies for 
immunoblotting were as follows: rabbit anti-CAG53b (1:1,000; Scherzinger 
et al., 1997), mouse anti-GFP (1:2,000; Takara Bio Inc.), rabbit anti-GST 
(1:500; Z-5; Santa Cruz Biotechnology, Inc.), mouse anti-polyQ (1:2,000; 
1C2; Millipore), mouse anti-Ku70 (1:500; N3H10; Kamiya Biomedical), 
rabbit anti-Ku70 (1:1,000; H-308; Santa Cruz Biotechnology, Inc.), rabbit 
anti-Ku80 (1:1,000; H-300; Santa Cruz Biotechnology, Inc.), rabbit anti-
DNA–PKcs (1:500; H-163; Santa Cruz Biotechnology, Inc.), mouse anti-
H2AX (1:500; Ser139; Millipore), rabbit anti-HD1 (1:2,000; Scherzinger 
et al., 1997), rabbit anti-HDAC3 (1:500; Millipore), mouse anti-GAPDH 
(1:10,000; Millipore), HRP-conjugated anti–goat IgG (Dako), anti–mouse 
IgG (GE Healthcare), and anti–rabbit IgG (1: 3,000; GE Healthcare).   
Antibodies were diluted in TBS with Tween 20 (TBST) with 5% skim milk.
IP
For IP, cells were lysed in TNE buffer (10 mM Tris-HCl, pH 7.8, 10% NP-40, 
0.15 M NaCl, and 1 mM EDTA) containing protease inhibitors (protease 
inhibitor cocktail; Roche) and 1 mM PMSF at 4°C for 1 h and centrifuged 
at 15,000 g for 20 min. The cell lysate was preincubated with protein G–
Sepharose (GE Healthcare) for 2 h at 4°C and centrifuged at 15,000 g for   
20 min. The supernatant lysate (1–2 µg/µl lysate protein) was incubated over-
night with an appropriate antibody at 4°C and incubated with protein G– 
Sepharose for 2 h at 4°C. After extensive washing in TNE buffer, the 
Sepharose beads were collected by centrifugation at 15,000 g for 5 min 
and boiled in 20 µl of lysis buffer containing 0.01% bromophenol blue, 
and 5 µl of the eluted proteins was resolved by SDS-PAGE.
The dilution conditions of antibodies used for IP were as follows: rab-
bit anti-GFP (1:200; Takara Bio Inc.), rabbit anti-Ku70 (1:50; H-308; Santa 
Cruz Biotechnology, Inc.), 10 µg/sample rabbit antiacetylated lysine (Stress-
gen), mouse anti-polyQ (1:500; 1C2; Millipore), and 2 µg/sample control 
IgG (mouse IgG1 and rabbit IgG; Santa Cruz Biotechnology, Inc.).
Deletion constructs of Ku70
Different regions of Ku70 cDNA described in Fig. 3 C were PCR amplified 
and  subcloned  into  an  EcoRI–BamHI  site  of  p3xFlag-CMV10  (Sigma-
Aldrich).  HEK293FT  cells  (Invitrogen)  transfected  with  the  Flag-Ku70 
plasmid and GFP-HttQ88 plasmid were lysed with WCE buffer (50 mM 
Tris-HCl, pH 8.0, 280 mM NaCl, 1% NP-40, 0.2 mM EGTA, 2 mM 
EDTA, and 10% glycerol) 48 h after transfection. The clarified cell lysate 
was incubated with M2 agarose beads (Sigma-Aldrich) to purify Flag 
proteins by immunoaffinity. Copurified proteins were analyzed by immuno-
blot analysis.
Tet-on stable cell lines and quantification of induced Htt genes
To prepare tetracyclin-controlled expression plasmids, the coding region 
of EGFP, EGFP-HttQ17, or EGFP-HttQ88 was PCR amplified with a for-
ward primer with BamHI site and a reverse primer with EcoRI site using   
pEGFP-C1 (Takara Bio Inc.), pEGFP-HttQ17, or pEGFP-HttQ17 as a tem-
plate, respectively. The PCR products were subcloned into a BamHI–EcoRI 
site  of  pcDNA4/TO/Myc-His  (Invitrogen).  T-Rex–HeLa  cells  (Invitrogen) 
genetically determined but indirectly or secondarily acquired 
by accumulation of the toxic species of mutant Htt protein.
Although some pathologies, including transcription, splic-
ing, proteasome dysfunction, and autophagy are implicated in 
multiple polyQ diseases, the spectra of binding partners are 
clearly different among mutant polyQ proteins (Goehler et al., 
2004; Lim et al., 2006). In the case of mutant Atx1, normal 
binding partners, including Capicua and RBM17, play critical 
roles in the pathology through gain of function or loss of func-
tion (Emamian et al., 2003; Lam et al., 2006; Lim et al., 2008). 
In  our  current  analyses  with  cellular  and  Drosophila  SCA1 
models, the rescue effects of Ku70 on the SCA1 pathology were 
smaller than that on the HD pathology (unpublished data). 
Therefore, Ku70 seems to be a specific pathological regulator to 
HD at this moment. Meanwhile, DNA damage by itself is shared 
by the SCA1 pathology through high mobility group protein B 
proteins (Qi et al., 2007), and it is still possible that other mole-
cules regulate DNA damage in SCA1 in addition to HMGBs.
Transcriptional repression in the HD pathology has been 
suggested by various research groups (Okazawa, 2003; Sugars and 
Rubinsztein, 2003; Hoshino et al., 2006). Accumulation of DNA 
damage causes transcriptional repression during transcription-
coupled repair and induces apoptotic signals (for review see 
Sancar et al., 2004). Nonrepaired DSB foci will attract ATM 
and associated molecules (Bekker-Jensen et al., 2006), activate 
Chk1 and 2, and initiate apoptotic signaling (for review see 
Sancar et al., 2004). Insufficient function of Ku70 might also 
enhance  ATM-mediated  signaling,  as  persistent  phosphory-
lation of p53 at Ser18 by the ATM activity was observed in   
irradiated Ku70-deficient cells in contrast to transient activation 
of p53 in control cells (Tomimatsu et al., 2007).
Moreover,  Ku70  is  known  to  be  involved  in  telomere 
homeostasis (Laroche et al., 1998; Riha et al., 2002). It is usu-
ally localized at telomere DNA (Bailey et al., 1999; Hsu et al., 
1999), whereas it relocalizes to DNA damage foci (Martin et al., 
1999). The two functions seem to be controlled by distinct faces 
of the Ku70 molecule (Ribes-Zamora et al., 2007). Mutant Htt 
might disorganize the dynamism of Ku70 between telomere and 
DSB foci. As telomere instability is implicated in neurodegenera-
tion (Zhang et al., 2007), the second function of Ku70 could be 
involved in the HD pathology. The additional functions of Ku70 
other than DNA repair will be the subject of future studies.
Materials and methods
Primary neuron culture and adenovirus infection
Primary neuron culture and adenovirus constructs were performed as previ-
ously described (Qi et al., 2007). Exon 1 from the human Htt gene contain-
ing  90  or  20  CAG  repeats  was  cleaved  from  pTL1HA3-CAG90  or 
pTL1HA3-CAG20 (Sittler et al., 2001) and subcloned into the pAxCAwt 
cosmid (Takara Bio Inc.). During subcloning, polyQ length was further ex-
panded to 111Q in the mutant Htt adenovirus vector. We designated the 
adenovirus vectors AxCA, AxCAhtt111Q, and AxCAhtt20Q. The resultant 
cosmids were used for the generation of adenovirus vectors by the Adeno-
virus Expression Vector kit (Takara Bio Inc.). After two or three amplifica-
tions,  clonality  of  the  vectors  (5  ×  10
8–10
9  PFU/ml)  was  checked  by 
restriction enzymes and PCR. The vectors were used for infection of neu-
rons at a multiplicity of infection of 100.
Primary neurons were prepared from the cerebral cortex of 18-d-
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for immunostaining were as follows: mouse anti-H2AX antibody (1:500; 
Ser139; Millipore), rabbit anti-Ku70 antibody (1:200; H-308; Santa Cruz 
Biotechnology, Inc.), mouse anti-Htt antibody (1:100; EM-48; Millipore), 
rabbit anti-Htt antibody CAG53b (1:400), biotin-conjugated mouse anti-NeuN 
antibody (1:100; Millipore), and rabbit antifibrillarin (1:200; Abcam).
Quantification of immunostain signals
The digital images were collected using a living cell imaging system of 
microscopy (IX71; Olympus) with a UPlan S Apo 20× 0.75 NA and 40× 
0.90 NA objective lens and a charge-coupled device camera (DP30BW; 
Olympus) at room temperature. The fluorescence signal intensities of immuno-
stained neurons (NeuN-positive cells) were calculated from at least three 
different slides of a brain sample, and >100 cells were measured in each 
sample by MetaMorph software (Universal Imaging Corporation). The sig-
nal intensity per cell was calculated by demarcating the cell nucleus. Mean 
pixel intensities within the image were measured, and background signals 
were subtracted. To calculate background signals, we measured fluores-
cence of 10 randomly selected noncell-existing tissue areas of each slide, 
and their mean value was subtracted from the cellular fluorescence signals 
on the same slide. The mean of the signal intensities after background sub-
traction was calculated in each brain sample, and the mean values of each 
group (mouse brain samples, n = 4–6; human brain samples, n = 3) were 
statistically  analyzed  between  the  groups.  Acquired  images  were  pro-
cessed with Photoshop software (Adobe).
Confocal images were acquired at room temperature using a con-
focal laser-scanning microscope (LSM 510 Meta; Carl Zeiss, Inc.) and a 
63× 1.4 NA oil immersion objective lens and processed using LSM image 
browser (Carl Zeiss, Inc.). Signal intensity profiles for Fig. 4 C were also 
obtained using LSM image browser, and the background signal intensity 
was subtracted from the signals. Brightness, contrast, and  of the acquired 
images were adjusted with LSM image browser and Photoshop software.
Comet assay
DNA DSBs were evaluated using the neutral single-cell gel electrophoresis 
assay (comet assay) as described previously (Olive and Banáth, 2006) with 
minor  modifications  (CometAssay;  Trevigen).  Cells  were  harvested,  sus-
pended with ice-cold PBS at 5 × 10
5/ml, mixed with 1% low melting point 
agarose at a ratio of 1:10 (vol/vol), and spread gently onto a coverslip to 
avoid creating bubbles. The agarose was allowed to solidify at 4°C, and 
the slides were immersed in ice-cold fresh lysis solution for 30 min at 4°C 
in a dark chamber. After lysis, the slides were equilibrated for 20 min with   
TBE buffer (90 mM Tris, 90 mM boric acid, and 2 mM EDTA, pH 8.0), 
and electrophoresis was performed in TBE buffer at 27 V for 20 min. After 
electrophoresis, the slides were air dried at room temperature; then, individual 
cells were stained with SYBR green I solution and viewed using a UV light 
fluorescence microscope. Quantification was achieved by analyzing at least 
50 randomly selected comets per slide with the Comet software (National 
Institutes of Health) using the following parameters: tail length (estimated 
leading edge from the nucleus in micrometers), L/H (the ratio of tail length to 
head diameter), and tail moment (arbitrary units; defined as the product of 
the percentage of DNA in the tail multiplied by the tail length).
We used CPT as a positive control in the neutral comet assay be-
cause CPT initially forms nicks in genome DNA through inhibition of TopI. 
TopI relieves torsion stress of DNA by nick formation with the cleavage 
complex (Wang, 2002). Although TopI cleavage complexes are normally 
very short lived and the nick is normally repaired by TDP1 and other fac-
tors, the nick leads to TopI-linked SSBs or DSBs by collision of the TopI 
cleavage  complex  with  the  transcription  or  replication  machinery.  CPT 
treatment increases the half-life of the TopI cleavage complex and similarly 
induces TopI-associated SSBs and DSBs (Katyal et al., 2007). Furthermore, 
a recent study showed that CPT induces DSBs in postmitotic primary neu-
rons (Sordet et al., 2009). All of these previous results support the usage of 
CPT as a positive control.
Coprecipitation assay
Transfection  into  HeLa  and  HEK293  cells  was  performed  with  Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s instructions 
and cultured for another 2 d. For Fig. S1 C, HEK293 cells were cultured 
in DME supplemented with 10% fetal bovine serum at 37°C and 5% CO2. 
pFlag-CMV-D11-Htt (N-terminal 506 amino acids containing 145 gluta-
mines) and pcMyc-CMV-D12-Ku70 were cotransfected using Lipofectamine 
2000 (Invitrogen) following the manufacturer’s instructions. After 48 h of 
transfection, the cells were pelleted and lysed in IP buffer (50 mM Tris,   
pH 7.6, 150 mM NaCl, 1% Triton X-100, and 10% glycerol) in the pres-
ence of protease inhibitor cocktail (Roche). Mouse IgG–coated magnetic 
beads (Dynabeads M-280; Invitrogen) were washed three times using IP buffer. 
were transfected with the tetracyclin-controlled expression plasmid; posi-
tive clones were selected with 200 ug/ml zeocin in minimum essential   
media supplemented with 10% fetal bovine serum to establish inducible 
stable cell lines. Semiquantification of induced EGFP-Htt and endogenous 
Htt in the Tet-on stable cells was performed with 5-GACCCTGGAAAAGCT-
GATGA-3 for Htt-RT-F2 and 5-GGCTGAGGAAGCTGAGGAG-3 for 
Htt-RT-R1 using PfuUltra II fusion HS DNA polymerase. The following primers 
were used for GAPDH: GAPDH-f, 5-GAGCCACATCGCTCAGAC-3; and 
GAPDH-r, 5-GGCCATCACGCCACAGTT-3. The PCR cycle is as follows: 
95°C for 2 min, 35 cycles of 95°C for 20 s, 56°C for 20 s, 72°C for 15 s,   
and a final extension at 72°C for 3 min.
Preparation of nuclear and cytoplasmic proteins
To prepare the cytoplasmic and nuclear protein extracts, cultured neurons 
were washed three times with ice-cold PBS, pH 7.4, and centrifuged at 
1,000 g for 5 min at 4°C. The cell pellets were resuspended in 8 vol of the 
hypotonic buffer (20 mM Hepes, pH 7.9, 10 mM KCl, 2 mM MgCl2, 0.3% 
Nonidet P-40, 1 mM DTT, 1 mM EDTA, protease inhibitor cocktail [Roche], 
and 1 mM PMSF) and placed on ice for 20 min. The extracts were centri-
fuged at 15,000 g for 20 min at 4°C. The supernatants were collected as 
the cytoplasmic extracts. The pellets were resuspended in 50 µl of the ex-
traction buffer (20 mM Hepes, pH 7.9, 420 mM NaCl, 1 mM EDTA, 2 mM 
MgCl2, 10% glycerol, 1 mM DTT, and protease inhibitor cocktail) and 
placed on ice for 20 min. The extracts were centrifuged at 15,000 g for 
20 min at 4°C, and the supernatants were used as the nuclear extracts. 
These samples were separated by SDS-PAGE, transferred onto polyvinyli-
dene difluoride membrane Fine Traps (Nihon Eido) by a semidry method, 
blocked by 5% milk in TBST (10 mM Tris/Cl, pH 8.0, 150 mM NaCl, and 
0.05% Tween 20), and incubated with appropriate antibodies (see follow-
ing paragraph). The filters were incubated with each primary antibody 
overnight at 4°C with the corresponding HRP-conjugated second antibody 
for 1 h at room temperature in 5% milk/TBST. Finally, the target molecules 
were visualized through an enhanced chemiluminescence Western blotting 
detection system (GE Healthcare).
Immunocytochemistry of primary neurons
Cultured neurons were fixed with 4% paraformaldehyde in 0.1 M phos-
phate buffer, pH 7.4, for 30 min, washed three times with PBS, blocked 
with 0.5% skim milk in PBS for 30 min at room temperature, and incubated 
with primary antibodies in PBS containing 0.5% skim milk and 0.1% Triton 
X-100 overnight at 4°C. The dilution conditions of primary antibodies for 
immunostaining were as follows: goat anti-Htt antibody (1:100; EM-48; 
Millipore), mouse anti-H2AX (1:500; Ser139; Millipore), and anti-Ku70 
antibody (1:200; H-308; Santa Cruz Biotechnology, Inc.). Incubation with 
the secondary antibodies of Alexa Fluor 488– or 594–labeled anti-IgGs 
(Invitrogen) diluted at 1:500 in 0.5% skim milk in PBS was performed for 
1 h at room temperature. For 8-oxo-dG (8-oxo-deoxyguanosine) staining, 
cells were fixed with 4% paraformaldehyde, treated with 3 M HCl for   
30 min at room temperature, and washed three times with PBS. Cells were 
incubated with 5 mg/ml RNaseA for 1 h at room temperature, washed 
three times with PBS, and further incubated with anti–8-oxo-dG antibody 
(MOG-020P; JaICA) diluted at 1:100 in buffer G (0.3% Triton X-100 and 
5% goat serum in PBS) overnight at 4°C. 8-oxo-dG signal was detected 
by using Alexa Fluor 594 IgG diluted at 1:1,000 in buffer G. Finally, cells 
were counterstained with DAPI (0.2 µg/ml in PBS) for nuclear staining and 
mounted for microscopic observations (IX70; Olympus).
Immunohistochemistry of brain tissues
Brain tissues were prepared from R6/2 and mutant Htt99Q knock-in mice 
(Htt 97CAG + 2CGG) whose phenotype onset is 45 wk (Ishiguro et al., 
2001; Sawada et al., 2007). Mouse brains were fixed in 4% paraformal-
dehyde for 12–16 h. For human pathology, HD human patient brains and 
nonneurological disease brains (leukemia or pneumonia) were used for 
analysis with agreement of their family and approval of the ethics com-
mittee. The paraffin-embedded mouse sections were deparaffinized, re-
hydrated, and microwaved in 10 mM of citrate buffer, pH 6.0, at 120°C 
for 15 min. These sections were incubated sequentially with 3% hydrogen 
peroxide for 20 min at room temperature to inhibit endogenous peroxi-
dase followed by incubation with primary antibodies overnight at 4°C and 
finally with Alexa Fluor 488– and 594–labeled anti-IgGs (Invitrogen) for 1 h 
at room temperature. Signal intensity per cell was calculated as described 
in the following section. More than 100 cells from at least three different 
slides were measured. To exclude background fluorescence, we measured 
fluorescence of 10 randomly selected noncell-existing tissue areas of each   
sample,  and  their  mean  value  was  subtracted  from  the  fluorescence 
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reagent (diluted 1:10 in deionized water) was added. The suspension 
was vortexed for 1 min and centrifuged at 5,000 g for 15 min at 4°C. 
The pellet was suspended with diluted BugBuster reagent and centrifuged 
at 16,000 g for 20 min at 4°C. This wash step was repeated three times, 
and the final pellet was stored at 80°C until use. Protein concentration 
was quantified by using the BCA method, and expression levels of en-
coded proteins were examined by immunoblotting.
DNA-dependent protein kinase activity assay
Nuclear extract was isolated from HeLa cells with a Nuclear Extraction 
kit (Active Motif) or from mouse cerebral cortex and striatum by the previ-
ously described method of Dignam et al. (1983). DNA–PK activity was 
determined by a DNA–PK assay system (SignaTECT; Promega) accord-
ing to the manufacturer’s instructions with minor modifications. In brief,   
0.4 mM biotinylated peptide substrate in a reaction buffer containing   
50 mM Hepes, pH 7.5, 100 mM KCl, 10 mM MgCl2, 0.1 mM EDTA,   
0.2 mM EGTA, 1 mM DTT, 0.1 mM ATP, and 0.5 µCi -[
32P]ATP was 
added to a DNA–PK activation buffer (0.25 µg calf thymus) or a con-
trol buffer (1 mM Tris-HCl, pH 7.4, and 0.1 mM EDTA, pH 8.0) and 
preincubated at 30°C for 5 min. Reactions were initiated by adding the 
preincubated mixture to 10 µl DNA–PK solution containing 116 U DNA–PK   
(purified  from  HeLa  cells;  Promega)  and  appropriate  amounts  of  GST, 
GST-Htt20Q, and GST-Htt110Q. The final volume was adjusted to 25 µl 
and incubated at 30°C for 20 min. Reactions were stopped with 12.5 µl 
of termination buffer (2.5 M guanidine hydrochloride) and spotted onto 
biotin capture membranes (SAM2; Promega). Membranes were washed 
in 2 M NaCl, in 2 M NaCl in 1% H3PO4, and finally in deionized water.   
Radioactivity  was  analyzed  using  a  phosphorimaging  system  (Bass 
FL3000; Fujifilm) as the counts of 
32P incorporated in the presence of DNA 
minus the counts of 
32P incorporated in the absence of DNA. The DNA–PK 
activity was calculated as described in the kit protocol.
As the substrate peptide is known to be a target for the PI3-kinase 
family members ATM, ATM related, and DNA–PK (Lees-Miller et al., 1992; 
Canman et al., 1998; Tibbetts et al., 1999), to demonstrate the specificity 
of DNA activation of the enzyme activity, the extracts (75 µg protein) were 
preincubated with active or inactive (heat inactivated at 80°C for 30 min) 
0.1% DNase I (Roche) for 2 h at 4°C. The DNA–PK enzymatic activity was 
determined by subtracting the activity in the extract incubated with active 
DNase I from that incubated with inactive one.
Ku70–DNA-binding activity
The  Ku70–DNA-binding  activity  was  analyzed  by  Ku70–Ku86  DNA 
repair  kit  (Active  Motif)  according  to  the  manufacturer’s  instructions. 
Nuclear extract was isolated from HeLa cells with a nuclear extraction 
kit (Active Motif) or from mouse cerebral cortex and striatum by the pre-
viously described method of Dignam et al. (1983). The HeLa nuclear 
extract (5 µg protein) and 150 ng GST, GST-Htt20Q, or GST-Htt110Q 
protein were mixed and incubated for 60 min at room temperature in 
the oligonucleotide-coated 96-well plate. After three steps of washing, 
Ku70 antibody was added followed by the HRP-conjugated secondary 
antibody. Each antibody was incubated for 60 min at room temperature. 
After four steps of washing, developing and stop solutions were added. 
Optical density was measured by spectrophotometer at 450 nm. The 
data represent the mean ± SD of three separate determinations. For the 
detection of Ku70–DNA-binding activity in mouse brain, 75 µg nuclear 
extract prepared from cerebral cortex and striatum was directly loaded 
into the plate. The Ku70–DNA-binding activity was detected as described 
in the previous paragraph.
Ku70–Ku80 interaction
IP and immunoblotting methods are described in the previous paragraph.
Inducible expression of mutant Htt
The pTRE-Tight-BI-DsRed-Htt103Q plasmid was generated by subcloning 
human HD exon 1 cDNA digested from pTL1HA3-HD90Q (Sittler et al., 
2001) into pTRE-Tight-BI-DsRed vector (Takara Bio Inc.). During the sub-
cloning, CAG repeats were expanded to 103. GFP-H2AX was described 
previously (Siino et al., 2002). pTet-on (Takara Bio Inc.) and pTRE-Tight-
BI-DsRed-Htt103Q were cotransfected to HeLa cells. Expression of Htt and 
DsRed was induced by 1 µg/ml doxycycline.
Cdk1 and MAPK assay
The cells were washed three times with PBS and lysed by cell lysis buffer 
composed of 50 mM Tris HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 
1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 10 mM 
-glycerophosphate, 1 mM Na3VO4, protease inhibitor cocktail (Roche), 
750 µg cell lysate was incubated with 2 µl specific antibody (monoclonal 
anti-Flag [Sigma-Aldrich] and 9E10 c-Myc) for 1 h at 4°C. Antibody-bound 
protein complexes were isolated by incubating with 40 µl of the beads for 
1 h at 4°C. Subsequently, the beads were separated from the lysate and 
washed one time using IP buffer. The protein complexes were heat dena-
tured and analyzed by SDS-PAGE and Western blotting.
Ku70-shRNA knockdown and EGFP-Htt expression vectors
An  artificial  oligo  DNA  (5-GAATTCGGAAGAGATAGTTTGATTTGTGT-
GCTGTCCAAATCAAACTATCTCTTCCTTTTTTGGATCC-3)  was  designed 
from the sequence of siRNA against human Ku70 (Applied Biosystems) by 
addition of a loop and termination signal sequences. The complementary 
oligo was also synthesized, and the double strand subcloned between 
EcoRI–BamHI sites of pSIREN-DsRed-Express (BD).
The cDNA fragments encoding exon 1 of human Htt gene with 17 
or 88 CAG repeats were amplified by PCR as previously described (Sittler 
et al., 2001) and subcloned into pEGFP-C1 plasmid (Takara Bio Inc.). After 
verification by sequencing, the plasmids were transfected into HeLa cells 
maintained in DME supplemented with 10% fetal bovine serum. Transfec-
tion was performed with Lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions and cultured for another 2 d. The protein ex-
pression level was confirmed by immunoblotting cell lysates with antibodies 
against tagged EGFP proteins.
LUMIER assay
All  of  the  cDNAs  used  in  the  LUMIER  assay  were  subcloned  into  the   
LUMIER  plasmids  pPAReni-DM  and  pFireV5-DM  using  GATEWAY  tech-
nology. Human embryonic kidney HEK293 cells were seeded in 96-well 
plates and cultured in DME supplemented with 10% fetal bovine serum at 
37°C and 5% CO2. Cotransfection of the plasmids was performed using 
Lipofectamine 2000 (Invitrogen) following the manufacturer’s protocol. The 
analyses described in the following paragraph were performed after 24 h   
of transfection.
For the LUMIER assay, cells were lysed at 4°C for 40 min in 100 µl   
of lysis buffer containing 50 mM Hepes-KOH, pH 7.4, 150 mM NaCl, 
0.1% NP-40, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT, and 75 U/ml 
benzonase (Merck) in the presence of protease inhibitor cocktail (Roche). 
Cell  extracts  were  prepared  and  assessed  for  the  expression  of  the   
fusion  proteins  by  luciferase  assays.  Protein  complexes  were  isolated 
from 80 µl cell extracts using 5 µl IgG-coated magnetic beads (M-280 
sheep anti–rabbit IgG; Dynabeads; Invitrogen) and subsequently washed 
with 100 µl PBS. Binding (co-IP) of the firefly-V5–tagged fusion proteins 
to the PA-Renilla–tagged Ku70 was quantified by measuring the firefly 
luciferase activity in a luminescence plate reader (TECAN Infinite M200) 
using the Dual-Glo Luciferase Assay system (Promega). Renilla luciferase 
activity was also measured as a control for PA-Renilla luciferase binding 
to the IgG-coated magnetic beads. Each experiment was performed as 
triplicate transfection.
GST fusion proteins
Wild-type or mutant exon 1 cDNA (nucleotides 341–511) of the human   
HD  gene  (The  Huntington’s  Disease  Collaborative  Research  Group, 
1993)  was  amplified  from  the  cosmid  vectors  by  PCR  using  primers 
(forward)  5-AAAGGATCCAGGCCTTCGAGTCCCTC-3  and  (reverse)   
5-AAAGAATTCGCCGGGCCGGGTGGCGG-3 and subcloned into the 
BamHI–EcoRI sites of the expression vector pGEX-3X (GE Healthcare). The 
plasmids were verified by sequencing to have either 20 or 110 CAG 
repeats. During PCR, the number of CAG repeats was changed from 111 
to 110 in mutant cDNA.
Escherichia coli cells (BL21) were transformed with the plasmid, 
grown to an OD600 of 0.6, and the fusion protein was induced with   
0.5  mM  IPTG  for  3.5  h  according  to  the  manufacturer’s  protocol   
(GE Healthcare). GST fusion proteins were purified by BugBuster GST 
Bind Purification kit (EMD). 400 ml cultures of induced bacteria were 
centrifuged at 5,000 g for 30 min at 4°C, and the resulting pellets were 
resuspended in BugBuster reagent (5 ml reagent/g wet cell paste) con-
taining 0.1 mg/ml lysozyme, 25 U/ml benzonase nuclease, and prote-
ase inhibitors (protease inhibitor cocktail; Roche). After 20 min at room 
temperature, cells were centrifuged at 16,000 g for 30 min at 4°C. The 
supernatant was incubated with 2 ml 50% slurry of GST bind resin that 
had been washed three times with GST bind/wash buffer for 1 h and 
poured into a small column and washed with 10 ml GST bind/wash buf-
fer. The bound fusion protein was eluted with 2 ml of GST elution buffer 
and stored at 80°C until use. The original pellet was suspended with 
the same volume of BugBuster reagent containing 0.1 mg/ml lysozyme 
and incubated for 10 min at room temperature. 6 vol diluted BugBuster JCB • VOLUME 189 • NUMBER 3 • 2010   440
full-length  mutant  Htt  protein.  Fig.  S3  shows  suppression  of  DNA–PK 
activity by GST-Htt111Q fusion protein. Fig. S4 shows additional data 
of  Ku70-R6/2  double-transgenic  mice.  Fig.  S5  shows  nucleolar  local-
ization  of  H2AX  in  striatal  neurons  of  Ku70-R6/2  double-transgenic 
mice. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.200905138/DC1.
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and 1 mM PMSF at 4°C. The cell lysate was stored at 80°C until use. For 
Cdk1 kinase assay, 500 µl of protein samples (containing 650 µg protein) 
was incubated with 20 µl HCK gel (MBL International) for 2 h at 4°C. The 
gel was washed three times with cell lysis buffer and twice with wash buf-
fer (25 mM Hepes, pH 7.5, and 10 mM MgCl). The gel was mixed with 
kinase assay buffer composed of 25 mM Hepes, pH 7.5, 10 mM MgCl, 
10% (vol/vol) mouse vimentin peptide solution (SLYSSPGGAYC; MBL Inter-
national), and 0.1 mM ATP (Sigma-Aldrich), and the mixture was incu-
bated for 30 min at 30°C. The reaction was terminated by the addition of 
200 µl PBS containing 50 mM EGTA. The phosphorylation of mouse vimen-
tin peptides was detected using an ELISA MESACUP Cdc2/Cdk1 kinase 
assay  kit  (MBL  International)  according  to  the  manufacturer’s  protocol. 
For MAPK assay, 500 µl of protein samples (containing 500 µg protein) 
was incubated with 10 µl anti-MAPK/Erk1/2 agarose and conjugated   
(Millipore) for 2 h at 4°C. The gel was washed three times with cell lysis 
buffer and twice with wash buffer composed of 20 mM MOPS, pH 7.2, 
25 mM -glycerophosphate, 5 mM EGTA, 1 mM Na3VO4, and 1 mM DTT. 
The kinase assay was performed using a MAPK/Erk IP kinase assay kit 
(Millipore) according to the manufacturer’s protocol.
Generation of transgenic mice
To generate transgenic mice overexpressing mouse Ku70 in the nervous 
system, the RIKEN mouse FANTOM clone encoding full-length mouse Ku70 
was inserted downstream of the enhancer/promoter of the rat NSE gene 
(promoter; nucleotides 146,320,892–146,318,938 of AC_000072). The 
1.9-kb sequence upstream of the rat NSE gene, which had been identified 
as the NSE enhancer/promoter (Forss-Petter et al., 1990), was subcloned 
from the genome DNA of Brown Norway and Sprague-Dawley rats and 
inserted into pIRES-hrGFPII (Agilent Technologies) by replacing the cyto-
megalovirus promoter with SpeI and EcoRI sites. The full-length mouse Ku70 
cDNA was inserted downstream of the NSE enhancer/promoter in pIRES-
hrGFPII, which also includes the internal ribosome entry site and human-
ized recombinant GFPII. To distinguish endogenous and transgenic Ku70, a 
3xFlag tag sequence was added to the C terminus of Ku70 cDNA. The plas-
mid was digested with AscI and SgrAI, and the resultant 5.5-kb fragment 
was injected into fertilized mouse oocytes derived from C57BL/6 mice.
Ku70 transgenic mice (C57BL/6) were crossed with CBA mice to 
generate Ku70 transgenic male mice in the CBA × C57BL/6 background. 
Double-transgenic mice of Ku70 and mutant Htt (CBA × C57BL/6) were 
generated by crossing Ku70 transgenic male mice (CBA × C57BL/6) and 
R6/2  ovarian–transplanted  female  mice  (CBA  ×  C57BL/6).  The  R6/2 
mouse line was maintained by crossing R6/2 ovarian–transplanted female 
with CBA × C57BL/6 male mice.
Genomic DNA was extracted from the tail, and R6/2 mice were 
identified by PCR as described previously (Mangiarini et al., 1996). For 
genotyping of Ku70 transgenic mice, PCR was performed with the primers 
(forward)  5-CCTCGAGGAATTCAGCAAAC-3  and  (reverse)  5-GATTC-
GAACATAGCCCTGGA-3  that  amplify  the  200-bp  sequence  from  the 
NSE promoter to the Ku70 gene. Amplification was performed with Ex-Taq 
(Takara Bio Inc.); the condition was 94°C for 30 s for denaturing, 58°C for 
1 min for annealing, and 72°C for 30 s for extension by 45 cycles. The 
size of the product was 200 bp. The protein expression from the trans-
gene was confirmed by Western blotting by using antibodies against anti-
Flag  (1:3,000;  F3165;  Sigma-Aldrich)  and  anti-Ku70  (1:500;  H308; 
Santa Cruz Biotechnology, Inc.).
Mouse behavioral tests
For the rotarod test, mice were placed on a rotating rod (3.5 rpm), and the 
rotating speed was linearly increased to 35 rpm at 300 s and continued at 
35 rpm until 360 s (for 4- to 12-wk-old mice). Mice received three trials per 
day for three consecutive days. The mean latency to fall off the rotarod was 
recorded and used for subsequent analyses. For the footprint test, steps of 
the hind paws were recorded with ink during walking. The resulting foot-
print tracings were analyzed, measuring stride length for hind paws. Each 
measurement represented the mean over three steps. For the clasping test, 
mice were observed in 2-s time bins for 14 s. Each mouse was allocated a 
score of 1 for abnormal hindlimb movement and score of 0 in the absence 
of  any  abnormal  movement.  This  allowed  for  a  maximum  score  of  7.   
Behavioral data were subjected to one-way analysis of variance with geno-
type as the factor at each time point followed by a Bonferroni post hoc test. 
Survival curves were analyzed by the Kaplan–Meier method using Statcel2 
software; the survival ratio was statistically compared by log-rank test.
Online supplemental material
Fig. S1 shows activation of H2AX and 53BP1 in the nuclei of striatal 
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